Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
December-2020 Volume 22 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2020 Volume 22 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Sustained activation of C3aR in a human podocyte line impairs the morphological maturation of the cells

  • Authors:
    • Jing‑Min Zheng
    • Sha‑Sha Wang
    • Xiong Tian
    • De‑Jun Chen
  • View Affiliations / Copyright

    Affiliations: Department of Nephrology, Taizhou Hospital, Wenzhou Medical University, Linhai, Zhejiang 317000, P.R. China
    Copyright: © Zheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 5326-5338
    |
    Published online on: October 22, 2020
       https://doi.org/10.3892/mmr.2020.11626
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The C3a receptor (C3aR) has been reported to be involved in various physiological and pathological processes, including the regulation of cellular structure development. Expression of C3aR has been reported in podocytes; however, data concerning the role of C3aR in podocyte morphology is scarce. The aim of the present study was to examine the effect of C3aR activation on the architectural development of podocytes. An immortal human podocyte line (HPC) was transfected with a C3a expression lentivirus vector or recombinant C3a. SB290157 was used to block the activation of C3aR. The expression of C3a in HPC cells was analyzed by reverse transcription‑quantitative PCR (RT‑qPCR) and ELISAs. Phase contrast and fluorescence microscopy were used to observe the morphology of the podocytes. The adhesive ability of HPC cells was analyzed using an attachment assay. RT‑qPCR, cyto‑immunofluorescence and western blotting were used to determine the expression levels of the adhesion‑associated genes. The expression levels of carboxypeptidases in HPC cells was also detected by RT‑qPCR. Compared with the untransfected and control virus‑transfected HPC cells, the C3a‑overexpressing cells (HPC‑C3a) failed to expand their cell bodies and develop an arborized appearance in the process of maturation, which the control cells exhibited. In addition, HPC‑C3a cells presented with decreased adhesive capacity, altered focal adhesion (FA) plaques and decreased expression of FA‑associated genes. These effects were blocked by a C3aR antagonist; however, the addition of purified C3a could not completely mimic the effects of C3a overexpression. Furthermore, HPC cells expressed carboxypeptidases, which have been reported to be able to inactivate C3a. In summary, the results demonstrated that sustained C3aR activation impaired the morphological maturation of HPC cells, which may be associated with the altered expression of FA‑associated genes and impaired FA. Since chronic complement activation has been reported in renal diseases, which indicate sustained C3aR activation in renal cells, including podocytes and podocyte progenitors, the possible role of C3aR in the dysregulation of podocyte architecture and podocyte regeneration requires further research.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Hawksworth OA, Coulthard LG, Mantovani S and Woodruff TM: Complement in stem cells and development. Semin Immunol. 37:74–84. 2018.PubMed/NCBI

2 

Hawksworth OA, Coulthard LG and Woodruff TM: Complement in the fundamental processes of the cell. Mol Immunol. 84:17–25. 2017.PubMed/NCBI

3 

Kwan WH, van der Touw W, Paz-Artal E, Li MO and Heeger PS: Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J Exp Med. 210:257–268. 2013.PubMed/NCBI

4 

Peng Q, Li K, Sacks SH and Zhou W: The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. Inflamm Allergy Drug Targets. 8:236–246. 2009.PubMed/NCBI

5 

Sacks SH: Complement fragments C3a and C5a: The salt and pepper of the immune response. Eur J Immunol. 40:668–670. 2010.PubMed/NCBI

6 

Lim J, Iyer A, Suen JY, Seow V, Reid RC, Brown L and Fairlie DP: C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J. 27:822–831. 2013.PubMed/NCBI

7 

Ohinata K and Yoshikawa M: Food intake regulation by central complement system. Adv Exp Med Biol. 632:35–46. 2008.PubMed/NCBI

8 

Bénard M, Raoult E, Vaudry D, Leprince J, Falluel-Morel A, Gonzalez BJ, Galas L, Vaudry H and Fontaine M: Role of complement anaphylatoxin receptors (C3aR, C5aR) in the development of the rat cerebellum. Mol Immunol. 45:3767–3774. 2008.PubMed/NCBI

9 

Broders-Bondon F, Paul-Gilloteaux P, Gazquez E, Heysch J, Piel M, Mayor R, Lambris JD and Dufour S: Control of the collective migration of enteric neural crest cells by the Complement anaphylatoxin C3a and N-cadherin. Dev Biol. 414:85–99. 2016.PubMed/NCBI

10 

Xu XH, Peng HS, Sun MQ, Hu M, Zhang R, Wang WH, He XY and Xiao XR: C-terminal peptide of anaphylatoxin C3a enhances hepatic function after steatotic liver transplantation: A study in a rat model. Transplant Proc. 42:737–740. 2010.PubMed/NCBI

11 

Davoust N, Jones J, Stahel PF, Ames RS and Barnum SR: Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells. Glia. 26:201–211. 1999.PubMed/NCBI

12 

Rahpeymai Y, Hietala MA, Wilhelmsson U, Fotheringham A, Davies I, Nilsson AK, Zwirner J, Wetsel RA, Gerard C, Pekny M, et al: Complement: A novel factor in basal and ischemia-induced neurogenesis. EMBO J. 25:1364–1374. 2006.PubMed/NCBI

13 

Shinjyo N, de Pablo Y, Pekny M and Pekna M: Complement Peptide C3a Promotes Astrocyte Survival in Response to Ischemic Stress. Mol Neurobiol. 53:3076–3087. 2016.PubMed/NCBI

14 

Stokowska A, Atkins AL, Morán J, Pekny T, Bulmer L, Pascoe MC, Barnum SR, Wetsel RA, Nilsson JA, Dragunow M, et al: Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia. Brain. 140:353–369. 2017.PubMed/NCBI

15 

Shinjyo N, Ståhlberg A, Dragunow M, Pekny M and Pekna M: Complement-derived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells. Stem Cells. 27:2824–2832. 2009.PubMed/NCBI

16 

Schlondorff J: How many Achilles' heels does a podocyte have? An update on podocyte biology. Nephrol Dial Transplant. 30:1091–1097. 2015.PubMed/NCBI

17 

Nagata M: Podocyte injury and its consequences. Kidney Int. 89:1221–1230. 2016.PubMed/NCBI

18 

Reiser J and Sever S: Podocyte biology and pathogenesis of kidney disease. Annu Rev Med. 64:357–366. 2013.PubMed/NCBI

19 

Li X, Ding F, Zhang X, Li B and Ding J: The Expression Profile of Complement Components in Podocytes. Int J Mol Sci. 17:4712016.PubMed/NCBI

20 

Locatelli M, Buelli S, Pezzotta A, Corna D, Perico L, Tomasoni S, Rottoli D, Rizzo P, Conti D, Thurman JM, et al: Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement. J Am Soc Nephrol. 25:1786–1798. 2014.PubMed/NCBI

21 

Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW and Mundel P: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol. 13:630–638. 2002.PubMed/NCBI

22 

Boos L, Campbell IL, Ames R, Wetsel RA and Barnum SR: Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis. J Immunol. 173:4708–4714. 2004.PubMed/NCBI

23 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Δ Δ C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI

24 

Riveline D, Zamir E, Balaban NQ, Schwarz US, Ishizaki T, Narumiya S, Kam Z, Geiger B and Bershadsky AD: Focal contacts as mechanosensors: Externally applied local mechanical force induces growth of focal contacts by an mDia1-dependent and ROCK-independent mechanism. J Cell Biol. 153:1175–1186. 2001.PubMed/NCBI

25 

Yadav P, Goyal VD, Gaur NK, Kumar A, Gokhale SM, Jamdar SN and Makde RD: Carboxypeptidase in prolyl oligopeptidase family: Unique enzyme activation and substrate-screening mechanisms. J Biol Chem. 294:89–100. 2019.PubMed/NCBI

26 

Matthews KW, Mueller-Ortiz SL and Wetsel RA: Carboxypeptidase N: A pleiotropic regulator of inflammation. Mol Immunol. 40:785–793. 2004.PubMed/NCBI

27 

Reznik SE and Fricker LD: Carboxypeptidases from A to Z: Implications in embryonic development and Wnt binding. Cell Mol Life Sci. 58:1790–1804. 2001.PubMed/NCBI

28 

Horton ER, Byron A, Askari JA, Ng DHJ, Millon-Frémillon A, Robertson J, Koper EJ, Paul NR, Warwood S, Knight D, et al: Definition of a consensus integrin adhesome and its dynamics during adhesion complex assembly and disassembly. Nat Cell Biol. 17:1577–1587. 2015.PubMed/NCBI

29 

Zaidel-Bar R, Cohen M, Addadi L and Geiger B: Hierarchical assembly of cell-matrix adhesion complexes. Biochem Soc Trans. 32:416–420. 2004.PubMed/NCBI

30 

Zamir E and Geiger B: Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci. 114:3583–3590. 2001.PubMed/NCBI

31 

Peng X, Maiers JL, Choudhury D, Craig SW and DeMali KA: α-catenin uses a novel mechanism to activate vinculin. J Biol Chem. 287:7728–7737. 2012.PubMed/NCBI

32 

Grashoff C, Hoffman BD, Brenner MD, Zhou R, Parsons M, Yang MT, McLean MA, Sligar SG, Chen CS, Ha T, et al: Measuring mechanical tension across vinculin reveals regulation of focal adhesion dynamics. Nature. 466:263–266. 2010.PubMed/NCBI

33 

Hemmings L, Rees DJ, Ohanian V, Bolton SJ, Gilmore AP, Patel B, Priddle H, Trevithick JE, Hynes RO and Critchley DR: Talin contains three actin-binding sites each of which is adjacent to a vinculin-binding site. J Cell Sci. 109:2715–2726. 1996.PubMed/NCBI

34 

Goldmann WH: Role of vinculin in cellular mechanotransduction. Cell Biol Int. 40:241–256. 2016.PubMed/NCBI

35 

Izard T and Brown DT: Mechanisms and functions of vinculin interactions with phospholipids at cell adhesion sites. J Biol Chem. 291:2548–2555. 2016.PubMed/NCBI

36 

Desban N, Lissitzky JC, Rousselle P and Duband JL: alpha1beta1-integrin engagement to distinct laminin-1 domains orchestrates spreading, migration and survival of neural crest cells through independent signaling pathways. J Cell Sci. 119:3206–3218. 2006.PubMed/NCBI

37 

Mruthyunjaya S, Parveen D, Shah RD, Manchanda R, Godbole R, Vasudevan M and Shastry P: Gene expression analysis of laminin-1-induced neurite outgrowth in human mesenchymal stem cells derived from bone marrow. J Biomed Mater Res A. 103:746–761. 2015.PubMed/NCBI

38 

Yamada M and Sekiguchi K: Molecular Basis of Laminin-Integrin Interactions. Curr Top Membr. 76:197–229. 2015.PubMed/NCBI

39 

Bachman H, Nicosia J, Dysart M and Barker TH: Utilizing Fibronectin Integrin-Binding Specificity to Control Cellular Responses. Adv Wound Care (New Rochelle). 4:501–511. 2015.PubMed/NCBI

40 

Iwamoto DV and Calderwood DA: Regulation of integrin-mediated adhesions. Curr Opin Cell Biol. 36:41–47. 2015.PubMed/NCBI

41 

Li Z, Lee H and Zhu C: Molecular mechanisms of mechanotransduction in integrin-mediated cell-matrix adhesion. Exp Cell Res. 349:85–94. 2016.PubMed/NCBI

42 

Sachs N and Sonnenberg A: Cell-matrix adhesion of podocytes in physiology and disease. Nat Rev Nephrol. 9:200–210. 2013.PubMed/NCBI

43 

Kanasaki K, Kanda Y, Palmsten K, Tanjore H, Lee SB, Lebleu VS, Gattone VH Jr and Kalluri R: Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus. Dev Biol. 313:584–593. 2008.PubMed/NCBI

44 

Dessapt C, Baradez MO, Hayward A, Dei Cas A, Thomas SM, Viberti G and Gnudi L: Mechanical forces and TGFbeta1 reduce podocyte adhesion through alpha3beta1 integrin downregulation. Nephrol Dial Transplant. 24:2645–2655. 2009.PubMed/NCBI

45 

He P, Liu D, Zhang B, Zhou G, Su X, Wang Y, Li D, Yang X, Hepatitis B and Virus X: Hepatitis B Virus X Protein Reduces Podocyte Adhesion via Downregulation of α3β1 Integrin. Cell Physiol Biochem. 41:689–700. 2017.PubMed/NCBI

46 

Borza CM, Su Y, Chen X, Yu L, Mont S, Chetyrkin S, Voziyan P, Hudson BG, Billings PC, Jo H, et al: Inhibition of integrin α2β1 ameliorates glomerular injury. J Am Soc Nephrol. 23:1027–1038. 2012.PubMed/NCBI

47 

Pozzi A, Jarad G, Moeckel GW, Coffa S, Zhang X, Gewin L, Eremina V, Hudson BG, Borza DB, Harris RC, et al: Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity. Dev Biol. 316:288–301. 2008.PubMed/NCBI

48 

Chen C, Li R, Ross RS and Manso AM: Integrins and integrin-related proteins in cardiac fibrosis. J Mol Cell Cardiol. 93:162–174. 2016.PubMed/NCBI

49 

Li SY, Mruk DD and Cheng CY: Focal adhesion kinase is a regulator of F-actin dynamics: New insights from studies in the testis. Spermatogenesis. 3:e253852013.PubMed/NCBI

50 

Mierke CT: The role of focal adhesion kinase in the regulation of cellular mechanical properties. Phys Biol. 10:0650052013.PubMed/NCBI

51 

Yasuda-Yamahara M, Rogg M, Frimmel J, Trachte P, Helmstaedter M, Schroder P, Schiffer M, Schell C and Huber TB: FERMT2 links cortical actin structures, plasma membrane tension and focal adhesion function to stabilize podocyte morphology. Matrix Biol. 68-69:263–279. 2018.PubMed/NCBI

52 

Heeringa SF and Cohen CD: Kidney diseases caused by complement dysregulation: Acquired, inherited, and still more to come. Clin Dev Immunol. 2012:6951312012.PubMed/NCBI

53 

Jalal D, Renner B, Laskowski J, Stites E, Cooper J, Valente K, You Z, Perrenoud L, Le Quintrec M, Muhamed I, et al: Endothelial microparticles and systemic complement activation in patients with chronic kidney disease. J Am Heart Assoc. 7:e0078182018.PubMed/NCBI

54 

Lesher AM and Song WC: Review: Complement and its regulatory proteins in kidney diseases. Nephrology (Carlton). 15:663–675. 2010.PubMed/NCBI

55 

Mizuno M, Suzuki Y and Ito Y: Complement regulation and kidney diseases: Recent knowledge of the double-edged roles of complement activation in nephrology. Clin Exp Nephrol. 22:3–14. 2018.PubMed/NCBI

56 

Salant DJ: Introduction: Complement-mediated kidney diseases. Semin Nephrol. 33:477–478. 2013.PubMed/NCBI

57 

Eng DG, Sunseri MW, Kaverina NV, Roeder SS, Pippin JW and Shankland SJ: Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis. Kidney Int. 88:999–1012. 2015.PubMed/NCBI

58 

Shankland SJ, Freedman BS and Pippin JW: Can podocytes be regenerated in adults? Curr Opin Nephrol Hypertens. 26:154–164. 2017.PubMed/NCBI

59 

Bao L, Osawe I, Haas M and Quigg RJ: Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis. J Immunol. 175:1947–1955. 2005.PubMed/NCBI

60 

Braun MC, Reins RY, Li TB, Hollmann TJ, Dutta R, Rick WA, Teng BB and Ke B: Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells. J Immunol. 173:4190–4196. 2004.PubMed/NCBI

61 

Horton ER, Byron A, Askari JA, Ng DHJ, Millon-Frémillon A, Robertson J, Koper EJ, Paul NR, Warwood S, Knight D, et al: Definition of a consensus integrin adhesome and its dynamics during adhesion complex assembly and disassembly. Nat Cell Biol. 17:1577–1587. 2015.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zheng JM, Wang SS, Tian X and Chen DJ: Sustained activation of C3aR in a human podocyte line impairs the morphological maturation of the cells . Mol Med Rep 22: 5326-5338, 2020.
APA
Zheng, J., Wang, S., Tian, X., & Chen, D. (2020). Sustained activation of C3aR in a human podocyte line impairs the morphological maturation of the cells . Molecular Medicine Reports, 22, 5326-5338. https://doi.org/10.3892/mmr.2020.11626
MLA
Zheng, J., Wang, S., Tian, X., Chen, D."Sustained activation of C3aR in a human podocyte line impairs the morphological maturation of the cells ". Molecular Medicine Reports 22.6 (2020): 5326-5338.
Chicago
Zheng, J., Wang, S., Tian, X., Chen, D."Sustained activation of C3aR in a human podocyte line impairs the morphological maturation of the cells ". Molecular Medicine Reports 22, no. 6 (2020): 5326-5338. https://doi.org/10.3892/mmr.2020.11626
Copy and paste a formatted citation
x
Spandidos Publications style
Zheng JM, Wang SS, Tian X and Chen DJ: Sustained activation of C3aR in a human podocyte line impairs the morphological maturation of the cells . Mol Med Rep 22: 5326-5338, 2020.
APA
Zheng, J., Wang, S., Tian, X., & Chen, D. (2020). Sustained activation of C3aR in a human podocyte line impairs the morphological maturation of the cells . Molecular Medicine Reports, 22, 5326-5338. https://doi.org/10.3892/mmr.2020.11626
MLA
Zheng, J., Wang, S., Tian, X., Chen, D."Sustained activation of C3aR in a human podocyte line impairs the morphological maturation of the cells ". Molecular Medicine Reports 22.6 (2020): 5326-5338.
Chicago
Zheng, J., Wang, S., Tian, X., Chen, D."Sustained activation of C3aR in a human podocyte line impairs the morphological maturation of the cells ". Molecular Medicine Reports 22, no. 6 (2020): 5326-5338. https://doi.org/10.3892/mmr.2020.11626
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team